Sight Sciences, Inc.·4

Feb 23, 4:28 PM ET

Badawi David 4

4 · Sight Sciences, Inc. · Filed Feb 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Sight Sciences (SGHT) CTO David Badawi Exercises Options

What Happened
David Badawi, Chief Technology Officer and a director of Sight Sciences (SGHT), exercised stock options on 2026-02-19 for 21,270 shares at an exercise price of $0.23 per share, paying $4,892 in total. The filing also reports 21,270 shares as disposed (derivative) on the same date — commonly the result of shares being surrendered or withheld to cover exercise costs or tax obligations.

Key Details

  • Transaction date: 2026-02-19; Form 4 filed: 2026-02-23 (appears timely).
  • Exercise details (code M): 21,270 shares acquired at $0.23 each; total amount paid $4,892.
  • Matching derivative disposition: 21,270 shares reported disposed at $0.00 (derivative reporting).
  • Shares owned after transaction: 1,795,520 shares of common stock beneficially owned, plus 202,938 shares that will be acquired upon future vesting of restricted stock units (per footnote).
  • Footnotes: F1 confirms these were option exercises under the company plan; F3 notes the option grant had fully vested as of Jan 1, 2020.
  • No 10b5-1 plan or other trading-plan disclosure in the filing; disposition reporting suggests withholding/surrender rather than an open-market sale.

Context
This was an option exercise rather than an open-market purchase or sale. When exercised options result in an equal number of shares being reported as disposed at $0.00, that often indicates shares were surrendered to cover the exercise price or taxes (a cashless or net-share settlement), not a market sale. Such exercises are common for insiders exercising long-vested options and do not by themselves signal a bullish or bearish view.

Insider Transaction Report

Form 4
Period: 2026-02-19
Badawi David
DirectorChief Technology Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-02-19$0.23/sh+21,270$4,8921,998,458 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F3]
    2026-02-1921,2700 total
    Exercise: $0.23Exp: 2026-02-28Common Stock (21,270 underlying)
Footnotes (3)
  • [F1]Reflects the exercise of stock options ("Options") awarded to the Reporting Person under the Issuer's equity incentive plan.
  • [F2]Includes (i) 1,795,520 shares of common stock, and (ii) 202,938 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units that have not yet vested.
  • [F3]The grant of Options made to the Reporting Person vested and became exercisable as to 25% of the underlying shares on January 1, 2017, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options became fully vested and exercisable on January 1, 2020.
Signature
/s/Jeremy Hayden, Attorney-in-Fact for David Badawi|2026-02-23

Documents

1 file
  • 4
    ownership.xmlPrimary

    4